Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Living Cell Technologies ( (AU:1AI) ) has provided an update.
Algorae Pharmaceuticals Ltd has released its corporate governance statement for the financial year ending 30 June 2025, which is available on their website. The statement confirms compliance with ASX Corporate Governance Council’s recommendations, detailing the roles and responsibilities of the board and management, and the accountability of the company secretary to the board. This announcement underscores Algorae Pharmaceuticals’ commitment to transparency and adherence to governance standards, potentially strengthening stakeholder confidence.
More about Living Cell Technologies
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$13.5M
Learn more about 1AI stock on TipRanks’ Stock Analysis page.